JPRN-UMIN000042914
Recruiting
未知
Clinical study of risk reducing salpingo-oophorectomy (RRSO) in patients with pathological variants of the BRCA1/2 gene - Clinical Study on RRSO in HBOC Patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hereditary Breast and Ovarian Cancer, HBOC
- Sponsor
- Sapporo Medical University
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients with active multiple cancers (concurrent multiple cancers requiring therapeutic intervention) 2\. Patients with a group of diseases that present severe systemic symptoms or active infectious diseases. 3\. Any other cases that are deemed inappropriate by the physician in charge.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Study on risk reducing salpingo-oophorectomy(RRSO) for BRCA1/2 mutation carriershereditary breast and ovarian cancerJPRN-UMIN000005292Cancer Institute Hospital Department of Gynecology, Breast center, Clinical Genetic Oncology200
Recruiting
Not Applicable
Study of risk reducing bilateral salpingo-oophorectomy (RRSO) for japanese BRCA1/2 mutation carriershereditary breast and ovarian cancerJPRN-UMIN000020648Juntendo University30
Recruiting
Not Applicable
Study on risk reducing bilateral salpingo-oophorectomy (RRSO) for BRCA1/2 mutation carriershereditary breast and ovarian cancerJPRN-UMIN000018302The Jikei university, school of medicine5
Completed
Not Applicable
Evaluation of risk-reducing salpingo-oophorectomy for patients with BRCA 1/2 mutatiohereditary breast and ovarian cancer: HBOCJPRN-UMIN000023606Kindai University Hospital
Recruiting
Not Applicable
Study on the effect of Risk-Reducing Salpingo-oophorectomy in hereditary breast and ovarian cancerHereditary breast and ovarian caccerJPRN-UMIN000023187Asahikawa Medical University10